PCSK9 and triple-A syndrome: Similar to the findings in AAA, PCSK9 expression may also be elevated in coronary artery aneurysms, suggesting that PCSK9 inhibitors may play a role in the prevention or regression of atherosclerotic coronary artery aneurysms.